Fitzgerald Kevin Joseph 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Fitzgerald Kevin Joseph（CIK 1886431）在 2 家公司共报告 96 笔 SEC Form 4 内部人交易（最近一笔 2026-04-09）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-04-09 | Ovid Therapeutics Inc. (OVID) | 董事 | 买入 | 17,578 | $45,000 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 57 | $18,563 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 28 | $8,960 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 59 | $18,928 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 79 | $25,424 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 96 | $31,009 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 210 | $68,006 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 75 | $24,366 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 124 | $39,904 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 233 | $75,317 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 148 | $48,041 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 153 | $49,915 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 29 | $9,252 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 289 | $91,483 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 买入 | 3,688 | $0 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 47 | $15,210 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 90 | $29,218 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 258 | $84,013 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 392 | $128,110 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 329 | $107,803 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 100 | $32,871 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 170 | $56,051 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 81 | $26,799 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 94 | $31,201 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | CSO & EVP, Head of Research | 卖出 | 37 | $12,308 |
来源：SEC Form 4 申报文件 · 截至 2026-04-09